Insitro
3 known investors
insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.
AI & Machine LearningBiotech
Founders & leadership
DK
Daphne KollerCEO & Founder
Investors · 3
In the news
- Insitro - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Insitro - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Insitro raises $400M for machine learning-powered drug discovery efforts | Fierce Biotechfiercebiotech.com · 2021
- Insitro raises $143m Series B - Drug Discovery and Developmentdrugdiscoverytrends.com · 2020
- Exclusive: Machine Learning Company Insitro Raises $143 Million To Bridge Biology And AIforbes.com · 2020
- Insitro Announces $143 Million Raised In Series B Financing | Reutersreuters.com · 2020